AQR Arbitrage LLC purchased a new position in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 597,535 shares of the business services provider's stock, valued at approximately $10,851,000. AQR Arbitrage LLC owned about 1.82% of Cross Country Healthcare as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Magnetar Financial LLC purchased a new position in Cross Country Healthcare during the 4th quarter valued at about $41,421,000. Alliancebernstein L.P. boosted its holdings in shares of Cross Country Healthcare by 443.7% during the 4th quarter. Alliancebernstein L.P. now owns 1,284,940 shares of the business services provider's stock valued at $23,335,000 after buying an additional 1,048,605 shares in the last quarter. Alpine Associates Management Inc. bought a new position in Cross Country Healthcare during the 4th quarter valued at approximately $10,552,000. Chicago Capital Management LLC bought a new position in shares of Cross Country Healthcare during the fourth quarter valued at $7,300,000. Finally, Hsbc Holdings PLC lifted its stake in shares of Cross Country Healthcare by 1,023.8% in the fourth quarter. Hsbc Holdings PLC now owns 413,575 shares of the business services provider's stock worth $7,502,000 after buying an additional 376,774 shares in the last quarter. 96.03% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
A number of research firms have commented on CCRN. StockNews.com initiated coverage on Cross Country Healthcare in a report on Tuesday, April 29th. They issued a "hold" rating for the company. Barrington Research restated a "market perform" rating and set a $18.61 target price on shares of Cross Country Healthcare in a research note on Friday, March 14th. Finally, JMP Securities reiterated a "market perform" rating on shares of Cross Country Healthcare in a research note on Thursday, February 6th. Six equities research analysts have rated the stock with a hold rating, According to data from MarketBeat, Cross Country Healthcare currently has a consensus rating of "Hold" and an average price target of $18.41.
Check Out Our Latest Report on CCRN
Cross Country Healthcare Trading Down 0.7 %
NASDAQ CCRN traded down $0.10 during trading hours on Monday, hitting $13.51. 201,157 shares of the company's stock traded hands, compared to its average volume of 592,691. Cross Country Healthcare, Inc. has a 52 week low of $9.58 and a 52 week high of $18.50. The firm has a market capitalization of $442.94 million, a P/E ratio of -270.15, a P/E/G ratio of 3.32 and a beta of 0.25. The business's fifty day moving average price is $14.94 and its two-hundred day moving average price is $15.39.
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
See Also

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.